CellCura

1
CellCura

• Nyvinning innen fertilitet
• Bioforum Telemark 17. april 2007

2
Dag Dvergsten AS

• 14 heltidsansatte
• Aktivt forretningsutviklingsmiljø innen energi,
  maritime virksomheter og teknologi.
• etablert og syndikert virksomheter med
  kapitalisert verdi over 2 mrd kroner over de
  siste 15 mnd.

3
CellCura highlights

• 2002
• ViG is approached by Jarl Kahn and Arne Sunde re
  financial support of developing business idea
• ViG presents concept to industrial innovator
  DDAS
• 2005
• CellCura AS is established with base in Porsgrunn
• The CellCura project is supported with loan from
  ViG and grants from Innovasjon Norge
• 2006
• NOK 15.000.000 raised in 2 private placements
• CellCura Inc. established
• 2007
• Signed collaboration agreement with WiCell,
  Wisconsin
• ART Workstation prototype assembled in Skien

4
Our mission

• Develop, manufacture and market novel products
  for Artificial Reproduction Technology (ART) and
  stem cells
• Improve treatment of infertility in humans and
  animals by offering safer, more efficient
  alternative products
• Grow with the stem cell industry to offer
  pre-requisite products to this industry as it
  evolves
• Mature into a complete service provider for our
  selected markets

5
Product Line
Initial product line
Product pipe-line

• Protein free media for human and animal assisted
  conception
• Media for stem cells
• Workstations for IVF clinics and stem cell
  applications

• Protein free media tool box for stem cell
  applications
• Other ART and stem cell lab consumables and
  equipment
• Service and annual support subscription
  (equipment)
• Financing package including purchase of existing
  equipment and re-sale to non-western countries
  via distribution channel